Session Details

S053 Consultative Dermatology for the Hospitalized Patient

Mon, Mar 10, 9:00 AM - 12:00 PM
W313
3 CME Available Symposium
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

The ultimate goal of this session is to equip attendees with practical and immediately applicable skills for inpatient and consult work within the house of medicine. In this high-yield session, expert Dermatology Hospitalists will review some of the most common skin diseases seen in consultation. Topics include: pediatric emergencies, severe cutaneous adverse reactions, retiform purpura, calciphylaxis, newer laboratory studies, and pearls for making consults more convenient for community and outpatient dermatologists. Information will be delivered in high-impact 20-minute specialty segments with an emphasis on practical practice points that are not readily available in the literature or textbooks.

LEARNING OBJECTIVES

1.

Identify cutaneous manifestations of systemic diseases, medication reactions, and infections as they present in the hospitalized patient with skin disease.

2.

Develop a working differential diagnosis, management plan, and treatment algorithm for hospitalized patients with skin disease.

3.

Apply a host of new tips and tricks for performing bedside diagnostics, obtaining samples and performing procedures.

SCHEDULE

1:00 PM

Welcome and Introduction

1:05 PM

Managing Severe Cutaneous Reactions: SJS, DRESS, and Drug-Induced Hypersensitivity

Steven T. Chen, MD, MPH, FAAD

1:30 PM

Calciphylaxis Demystified

Lindsay Chaney Strowd, MD, FAAD

2:00 PM

Acute Retiform Purpura: A Dermatologic Emergency

Robert Micheletti, MD, FAAD

2:30 PM

Advanced Laboratory Testing in Dermatology: Next Steps and Practical Tips

Karl Saardi, MD, FAAD

3:00 PM

Fitting it All In: Tips and Pearls for Participating in Inpatient Care as an Outpatient Dermatologist

Lindsay Ackerman, MD, FAAD

3:30 PM

Pediatric Dermatology Consults

Kalyani Marathe, MD, MPH, FAAD

3:55 PM

Final Q&A, Wrap Up, and Goodbye!

SPEAKERS

Lindsay Ackerman, MD, FAAD

Lindsay Ackerman, MD, FAAD

Steven T. Chen, MD, MPH, FAAD

Steven T. Chen, MD, MPH, FAAD

Kalyani Marathe, MD, MPH, FAAD

Kalyani Marathe, MD, MPH, FAAD

Robert Micheletti, MD, FAAD

Robert Micheletti, MD, FAAD

Helena Beth Pasieka, MD

Helena Beth Pasieka, MD

Karl Saardi, MD, FAAD

Karl Saardi, MD, FAAD

Lindsay Chaney Strowd, MD, FAAD

Lindsay Chaney Strowd, MD, FAAD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Lindsay Ackerman, MD, FAAD

AbbVie – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees), Speaker(Honoraria); Alumis – Investigator(Fees); Amgen – Investigator(Fees), Speaker(Honoraria); Apollo Therapeutics Ltd – Investigator(Fees); arGEN-X – Investigator(Fees), Speaker(Honoraria); AstraZeneca – Investigator(Fees); Biofrontera AG – Investigator(Fees); Boehringer Ingelheim – Investigator(Fees); Bristol-Myers Squibb – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Castle Biosciences – Investigator(Fees); ChemoCentryx – Investigator(Fees); CorEvitas – Investigator(Fees); Corrona, Inc. – Investigator(Fees); DermTech International – Investigator(Fees); Eli Lilly – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Exact Sciences – Investigator(Fees); GlaxoSmithKline Immunology – Investigator(Fees); Helsinn Healthcare – Speaker(Honoraria); IgGenix, Inc – Investigator(Fees); Incyte Corporation – Investigator(Fees); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Fees); Kymera Therapeutics – Investigator(Fees); Kyowa Kirin – Speaker(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Investigator(Fees); Lilly ICOS LLC – Advisory Board(Honoraria), Speaker(Honoraria); Merck – Investigator(Fees); Mindera – Investigator(Fees); Novartis – Advisory Board(Honoraria), Investigator(Fees); Pfizer Inc. – Investigator(Fees), Speaker(Honoraria); Regeneron – Investigator(Fees); Replimune – Investigator(Fees); Sanofi – Advisory Board(Honoraria), Investigator(Fees); Soligenix, Inc – Investigator(Fees); Sun Pharmaceutical Industries Ltd. – Investigator(Fees), Speaker(Honoraria); Takeda Pharmaceuticals USA Inc – Investigator(Fees); Timber Pharmaceuticals – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees); Trevi Therapeutics – Investigator(Fees); UCB – Advisory Board(Honoraria), Investigator(Fees); VeraDermics Inc. – Investigator(Fees); Zura Bio – Investigator(Fees);

Steven T. Chen, MD, MPH, FAAD

Vertex Pharmaceuticals Incorporated – Employee (w-2 relationship)(Salary); VisualDx – Independent Contractor(Fees);

Kalyani Marathe, MD, MPH, FAAD

Goodsprout company – Advisory Board(Honoraria); Janssen Biotech – Advisory Board(Honoraria); Oakstone – Speaker/Faculty Education(Honoraria); The Goodsprout Company, Inc. – Advisory Board(Honoraria); Verrica Pharmaceuticals Inc – Advisory Board(Honoraria);

Robert Micheletti, MD, FAAD

Acelyrin – Investigator(Grants/Research Funding); Boehringer Ingelheim – Investigator(Grants/Research Funding); Cabaletta Bio – Investigator(Grants/Research Funding); InflaRx – Investigator(Grants/Research Funding); Vertex Pharmaceuticals, Inc. – Consultant(Fees);

Helena Beth Pasieka, MD

No financial relationships exist with ineligible companies.

Karl Saardi, MD, FAAD

Boehringer Ingelheim – Speaker(Fees); Oakstone Publishing – Speaker/Faculty Education(Fees); Regeneron – Speaker/Faculty Education(Fees); UCB – Advisory Board(Fees); WebMD – Speaker(Fees);

Lindsay Chaney Strowd, MD, FAAD

No financial relationships exist with ineligible companies.